Patterns of Care and Treatment Outcomes of Elderly Patients with Stage I Esophageal Cancer: Analysis of the National Cancer Data Base

被引:45
作者
Moreno, Amy C. [1 ]
Verma, Vivek [2 ]
Hofstetter, Wayne L. [3 ]
Lin, Steven H. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, 1515 Holcombe Blvd,Unit 097, Houston, TX 77030 USA
[2] Univ Nebraska Med Ctr, Dept Radiat Oncol, Omaha, NE USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Thorac Surg, Houston, TX 77030 USA
关键词
Esophageal cancer; Elderly; Radiotherapy; Esophagectomy; Chemoradiotherapy; POPULATION-BASED ANALYSIS; PULMONARY COMPLICATIONS; MAJOR MORBIDITY; MORTALITY; SURGERY; RISK; RADIOTHERAPY; THERAPY; CHEMORADIOTHERAPY; PREDICTORS;
D O I
10.1016/j.jtho.2017.04.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: This study analyzes practice patterns, treatment-related mortality, survival, and predictors thereof in elderly patients with early-stage esophageal cancer (EC). Methods: The National Cancer Data Base was queried for cT1-2 NO EC in patients 80 years of age and older. Patients were divided into four treatment groups: observation (Obs), chemoradiotherapy (CRT), local excision (LE), and esophagectomy (Eso). Patient, tumor, and treatment parameters were extracted and compared. Analyses were performed on overall survival (OS) and postoperative 30- and 90-day mortality. Results: A total of 923 patients from 2004 to 2012 were analyzed. Of these, 43% underwent clinical Obs, 22% underwent CRT, 25% underwent LE, and 10% underwent Eso. Patients undergoing Obs were older, had more comorbidities, were treated at nonacademic centers, and lived 25 miles or less from the facility. Patients receiving an operation (Eso or LE) were more often younger, male, white, and in the top income quartile. The postoperative 30-day mortality rates in the LE and Eso groups were 1.3% and 9.6%, respectively (p < 0.001) and increased to 2.6% and 20.2% at 90 days, respectively (p < 0.001). The 5-year OS rate was 7% for Obs, 20% for CRT, 33% for LE, and 45% for Eso (p < 0.001). Multivariate analyses showed improved OS with any local definitive therapy: CRT (hazard ratio [HR] = 0.42, 95% confidence interval [CI]: 0.34-0.52, p < 0.001), LE (HR = 0.3, 95% CI: 0.24-0.38, p < 0.001), and Eso (HR = 0.32, 95% CI: 0.23-0.44, p < 0.001). Conclusions: There are noteworthy demographic, socioeconomic, and regional disparities influencing management of elderly patients with stage I EC. Despite high rates of Obs, careful consideration of all local therapy options is warranted, given the improved outcomes with treatment. (C) 2017 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:1152 / 1160
页数:9
相关论文
共 36 条
  • [1] American College of Surgeons, PART US FIL
  • [2] Outcomes after esophagectomy: A ten-year prospective cohort
    Bailey, SH
    Bull, DA
    Harpole, DH
    Rentz, JJ
    Neumayer, LA
    Pappas, TN
    Daley, J
    Henderson, WG
    Krasnicka, B
    Khuri, SF
    [J]. ANNALS OF THORACIC SURGERY, 2003, 75 (01) : 217 - 222
  • [3] Treatment Modalities for T1N0 Esophageal Cancers A Comparative Analysis of Local Therapy Versus Surgical Resection
    Berry, Mark F.
    Zeyer-Brunner, Josiane
    Castleberry, Anthony W.
    Martin, Jeremiah T.
    Gloor, Beat
    Pietrobon, Ricardo
    D'Amico, Thomas A.
    Worni, Mathias
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (06) : 796 - 802
  • [4] The National Cancer Data Base: A powerful initiative to improve cancer care in the United States
    Bilimoria, Karl Y.
    Stewart, Andrew K.
    Winchester, David P.
    Ko, Clifford Y.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (03) : 683 - 690
  • [5] Improving Outcomes for Esophageal Cancer using Proton Beam Therapy
    Chuong, Michael D.
    Hallemeier, Christopher L.
    Jabbour, Salma K.
    Yu, Jen
    Badiyan, Shahed
    Merrell, Kenneth W.
    Mishra, Mark V.
    Li, Heng
    Verma, Vivek
    Lin, Steven H.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 95 (01): : 488 - 497
  • [6] Chemoradiotherapy of locally advanced esophageal cancer - Long-term follow-up of a prospective randomized trial (RTOG 85-01)
    Cooper, JS
    Guo, MD
    Herskovic, A
    Macdonald, JS
    Martenson, JA
    Al-Sarraf, M
    Byhardt, R
    Russell, AH
    Beitler, JJ
    Spencer, S
    Asbell, SO
    Graham, MV
    Leichman, LL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (17): : 1623 - 1627
  • [7] ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES
    DEYO, RA
    CHERKIN, DC
    CIOL, MA
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) : 613 - 619
  • [8] Surgical Resection for Locoregional Esophageal Cancer Is Underutilized in the United States
    Dubecz, Attila
    Sepesi, Boris
    Salvador, Renato
    Polomsky, Marek
    Watson, Thomas J.
    Raymond, Daniel P.
    Jones, Carolyn E.
    Litle, Virginia R.
    Wisnivesky, Juan P.
    Peters, Jeffrey H.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2010, 211 (06) : 754 - 761
  • [9] Prediction of Major Pulmonary Complications After Esophagectomy
    Ferguson, Mark K.
    Celauro, Amy D.
    Prachand, Vivek
    [J]. ANNALS OF THORACIC SURGERY, 2011, 91 (05) : 1494 - 1500
  • [10] Endoscopic Management of Early Esophageal Neoplasia: an Emerging Standard
    Galey, Kelly M.
    Wilshire, Candice L.
    Watson, Thomas J.
    Schneider, Marabel D.
    Kaul, Vivek
    Jones, Carolyn E.
    Litle, Virginia R.
    Ullah, Asad
    Peters, Jeffrey H.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2011, 15 (10) : 1728 - 1735